(Q80244873)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18098207%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

The impact of prostate-specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18098207%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18098207%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Gabriel Sandblom

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18098207%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Sam Ladjevardi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18098207%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Eberhard Varenhorst

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18098207%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18098207%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18098207%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18098207%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18098207%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

813-819

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18098207%20AND%20SRC:MED&resulttype=core&format=json

EAU guidelines on prostate cancer

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of ≥8

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

Preoperative PSA and progression-free survival after radical prostatectomy for Stage T1c disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

Prostate-specific antigen levels as a predictor of lethal prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

Impact of preoperative serum PSA level from 0 to 10 ng/ml on pathological findings and disease-free survival after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

Geographical variation in incidence of prostate cancer in Sweden.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

Prostate cancer mortality in northern Sweden, with special reference to tumor grade and patient age

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

M1 prostate cancer with a serum level of prostate-specific antigen less than 10 ng/mL.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23235

7 January 2021

Identifiers

DOI

10.1002/CNCR.23235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18098207%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference